S&P Revises Royal & Sun Alliance Entities Outlooks

The following statement was released by the rating agency.

Published on July 8, 2003

NEW YORK, July 8 - Standard & Poor's Ratings Services said today it revised its outlook on various entities of U.K.-based Royal & Sun Alliance Insurance Group PLC (R&SA) to negative from developing. At the same time, Standard & Poor's affirmed its long-term counterparty credit and insurer financial strength ratings on the group.

In addition, Standard & Poor's affirmed its 'BBB' long-term junior subordinated debt rating on the notes issued by R&SA and guaranteed by Royal & Sun Alliance Insurance PLC (R&SAIP; local currency A-/Negative/--, foreign currency A-/Negative/A-2), the main operating company of R&SA. Standard & Poor's also affirmed its 'A-2' short-term debt rating on R&SAIP's $1 billion CP program.

"The outlook revision reflects Standard & Poor's concerns that the group may not achieve the necessary recovery in operating performance or fully deliver on the group restructuring and capital-release program," said Standard & Poor's credit analyst Rowena Potter. "These concerns relate primarily to the U.S. operations."

The ratings reflect R&SA's strong business position, poor recent operating performance, adequate capitalization, and restricted financial flexibility (defined as the ability to source capital relative to requirements).

The negative outlook reflects Standard & Poor's concerns that ongoing issues relating to reserve adequacy at the U.S. operations may hinder prospective group operating performance and capital formation.

Standard & Poor's expects the combination of increases in premium rates, risk reduction, and group restructuring to translate into a reported combined ratio of less than 102% in 2003, with an ROR in excess of 5%. The U.S. operations are collectively expected to achieve a combined ratio below 108%.

Significant progress has already been made in R&SA's wide-ranging restructuring and capital-release program, including the IPO of its Australian and New Zealand operations and the sales of the health business in the U.K. and Royal Specialty Underwriting Inc. in the U.S.

Nevertheless, there remains some risk that the group will be unable to restore capital adequacy into the 'A' range according to Standard & Poor's risk-based capital model by 2004, due primarily to concerns about the U.S. operations.